Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire Arrived EquityMultiple

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Top Smart Score Stocks

Plans & Pricing

Research Tools

Trending Stocks

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Economic Indicators

Economic Indicators Center

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Penny Stock Screener

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

CytoMed Therapeutics Limited (GDTC)

NASDAQ:GDTC

US Market

GDTC

CytoMed Therapeutics Limited

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

CytoMed Therapeutics Limited (GDTC) Stock News & Sentiment

8 Followers

CytoMed and SunAct Collaborate on Cancer Immunotherapy Trials in India

Company Announcements

CytoMed and SunAct Collaborate on Cancer Immunotherapy Trials in India

1M ago

CytoMed Therapeutics Expands Leadership Amid Strategic Growth

Company Announcements

CytoMed Therapeutics Expands Leadership Amid Strategic Growth

2M ago

CytoMed Reaches Milestone with New Cancer Therapy

Company Announcements

CytoMed Reaches Milestone with New Cancer Therapy

3M ago

CytoMed Launches Innovative CAR-T Cell Trial

Company Announcements

CytoMed Launches Innovative CAR-T Cell Trial

4M ago

CytoMed Acquires Cord Blood Assets, Eyes Regenerative Medicine

Company Announcements

CytoMed Acquires Cord Blood Assets, Eyes Regenerative Medicine

4M ago

CytoMed Therapeutics Reports Interim Financial Loss

Company Announcements

CytoMed Therapeutics Reports Interim Financial Loss

4M ago

CytoMed Announces Board Reorganization

Company Announcements

CytoMed Announces Board Reorganization

8M ago

More GDTC News >

GDTC News on the Web

2025-02-06

CytoMed Therapeutics announces Chairman’s Letter to the Company’s shareholders

Yahoo Finance

Neutral

2025-02-04

Anebulo Pharmaceuticals Leads This Trio Of US Penny Stocks

Yahoo Finance

Neutral

2025-01-07

CytoMed Therapeutics and SunAct to conduct solid tumour treatment trial in India

Clinical Trials Arena

Neutral

2025-01-06

CytoMed Soars On Research Deal With SunAct Cancer Institute For Solid Tumor Treatment Trial In India

rttnews

Neutral

2025-01-06

CytoMed and SunAct Collaborate on Cancer Immunotherapy Trials in India

TipRanks News

Neutral

2024-10-07

CytoMed Therapeutics’ first-in-human Phase I ANGELICA clinical trial using its patented donor allogeneic chimeric antigen receptor T cell against blood and solid tumors received co-funding support from the NMRC Clinical Trial Grant

Yahoo Finance

Neutral

2024-10-04

CytoMed Acquires Cord Blood Assets, Eyes Regenerative Medicine

Yahoo Finance

Neutral

2024-10-03

CytoMed Therapeutics completes cash acquisition of Cord Blood Banking Licence and Assets expanding CytoMed’s strategy to cord blood-derived biologics through subsidiary, LongevityBank

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

GDTC

Sector Average

Media Buzz

This Week2 articles

Weekly Average1 articles

News Sentiment

This Week50%

Sector Average59%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GDTC’s Media Buzz Sentiment?

2 articles about GDTC were published this week. In an average week, 1 articles are published.

What is GDTC’s weekly average amount of articles?

In an average week, 1 articles about GDTC are published.

What is GDTC’s News Sentiment?

50% of articles about GDTC were positive this week, compared to its sector average of 59%.

Healthcare Stocks that are Trending in the News

GHRSGH Research

CVRXCVRx

NVRONevro Corp

ZTSZoetis

IDXXIdexx Laboratories

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing